Dongling Hao

Title: The Innovative Contributions of Dongling Hao

Introduction

Dongling Hao is a notable inventor based in Shanghai, China. He has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that target critical pathways in tumor treatment. His work exemplifies the intersection of innovation and practical application in medical science.

Latest Patents

Dongling Hao holds a patent for a pyridino[1,2-α]pyrimidone analogue used as an MTOR/PI3K inhibitor. This invention relates to novel pyridino[1,2-α]pyrimidone compounds represented by a specific formula or pharmaceutically acceptable salts thereof. The method of use for these compounds is aimed at treating tumors, showcasing Hao's commitment to advancing cancer therapies. He has 1 patent to his name.

Career Highlights

Throughout his career, Dongling Hao has worked with prominent companies in the pharmaceutical industry. He has been associated with Cisen Pharmaceutical Co., Ltd. and Shanghai Jia Tan Pharmatech Co., Ltd. His experience in these organizations has allowed him to contribute to various innovative projects and research initiatives.

Collaborations

Dongling Hao has collaborated with several professionals in his field, including Huiping Amy Guan and Chengde Wu. These partnerships have likely enriched his research and development efforts, fostering a collaborative environment for innovation.

Conclusion

Dongling Hao's contributions to pharmaceutical innovation, particularly in cancer treatment, highlight his role as a significant inventor in the industry. His patent and collaborations reflect a dedication to advancing medical science and improving patient outcomes.